UBS Group AG current report, Q1 FY2021

Business Context and Reporting Period

This Form 6-K, filed on March 9, 2021, by UBS Group AG and UBS AG, serves to disseminate a news release regarding the agenda for the Annual General Meeting (AGM) scheduled for April 8, 2021. The filing addresses corporate governance matters, board elections, and capital allocation proposals for the 2020 financial year.

Key Financial Metrics

The filing does not provide specific revenue, profit, cash flow, margin, debt, or liquidity figures. The only specific financial metric disclosed is the proposed ordinary dividend for the 2020 financial year, which is set at USD 0.37 (gross) per share in cash.

Material Changes and Corporate Actions

  • Board Composition: Claudia Böckstiegel and Patrick Firmenich are nominated for election to the Board of Directors. Beatrice Weder die Mauro will not stand for re-election.
  • Capital Allocation: The Board proposes a capital reduction via the cancellation of shares repurchased under the 2018–2021 buyback program. Additionally, a new share buyback program for 2021–2024 is proposed for shareholder approval.
  • AGM Format: Due to the ongoing COVID-19 pandemic, the AGM will be held as a webcast rather than a physical event. Shareholders must exercise voting rights through an independent proxy.

Guidance, Outlook, and Risks

The filing contains no forward-looking financial guidance, earnings outlook, or management commentary on market conditions. The primary risk factor noted is the impact of the COVID-19 pandemic, which necessitated the virtual format of the AGM and restricted physical participation. The agenda includes an advisory vote on the 2020 Compensation Report and the discharge of the Board and Group Executive Board, excluding issues related to the French cross-border matter.

Investor Verification Checklist

  • Verify the final approval of the USD 0.37 ordinary dividend at the April 8, 2021 AGM.
  • Confirm the election results for new board members Claudia Böckstiegel and Patrick Firmenich.
  • Review the terms and authorization limits of the proposed 2021–2024 share buyback program.
  • Check the status of the capital reduction following the cancellation of shares from the 2018–2021 program.
  • Monitor updates regarding the "French cross-border matter" excluded from the discharge of directors.